HK1245826A1 - 用於治療營養不良性大疱性表皮鬆解症的反義寡核苷酸 - Google Patents
用於治療營養不良性大疱性表皮鬆解症的反義寡核苷酸Info
- Publication number
- HK1245826A1 HK1245826A1 HK18105119.5A HK18105119A HK1245826A1 HK 1245826 A1 HK1245826 A1 HK 1245826A1 HK 18105119 A HK18105119 A HK 18105119A HK 1245826 A1 HK1245826 A1 HK 1245826A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- antisense oligonucleotides
- epidermolysis bullosa
- dystrophic epidermolysis
- treat
- treat dystrophic
- Prior art date
Links
- 108020000948 Antisense Oligonucleotides Proteins 0.000 title 1
- 208000010975 Dystrophic epidermolysis bullosa Diseases 0.000 title 1
- 239000000074 antisense oligonucleotide Substances 0.000 title 1
- 238000012230 antisense oligonucleotides Methods 0.000 title 1
- 208000004298 epidermolysis bullosa dystrophica Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1508733.1A GB201508733D0 (en) | 2015-05-21 | 2015-05-21 | Antisense oligonucleotides |
| GBGB1516505.3A GB201516505D0 (en) | 2015-09-17 | 2015-09-17 | Antisense oligonucleotides |
| PCT/EP2016/061495 WO2016185041A1 (en) | 2015-05-21 | 2016-05-20 | Antisense oligonucleotides to treat dystrophic epidermolysis bullosa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1245826A1 true HK1245826A1 (zh) | 2018-08-31 |
Family
ID=56026883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18105119.5A HK1245826A1 (zh) | 2015-05-21 | 2018-04-19 | 用於治療營養不良性大疱性表皮鬆解症的反義寡核苷酸 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10370660B2 (zh) |
| EP (1) | EP3298144A1 (zh) |
| JP (2) | JP6871175B2 (zh) |
| KR (1) | KR20180012255A (zh) |
| CN (1) | CN107667174B (zh) |
| AU (1) | AU2016265457B2 (zh) |
| CA (1) | CA2986642A1 (zh) |
| EA (1) | EA036393B1 (zh) |
| HK (1) | HK1245826A1 (zh) |
| IL (1) | IL255180B2 (zh) |
| MX (1) | MX2017014855A (zh) |
| WO (1) | WO2016185041A1 (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6871175B2 (ja) | 2015-05-21 | 2021-05-12 | ウィングス セラピューティクス，インコーポレイテッド | ジストロフィー型表皮水疱症を処置するためのアンチセンスオリゴヌクレオチド |
| WO2016196670A1 (en) | 2015-06-01 | 2016-12-08 | Sarepta Therapeutics, Inc. | Antisense-induced exon exclusion in type vii collagen |
| GB201902735D0 (en) | 2019-02-28 | 2019-04-17 | Proqr Therapeutics Ii Bv | Oligonucleotides for use in the treatment of dystrophic epidermolysis bullosa |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
| US5952221A (en) | 1996-03-06 | 1999-09-14 | Avigen, Inc. | Adeno-associated virus vectors comprising a first and second nucleic acid sequence |
| US20040023378A1 (en) * | 2002-07-31 | 2004-02-05 | Isis Pharmaceuticals Inc. | Antisense modulation of KIAA1531 protein expression |
| EP1857548A1 (en) * | 2006-05-19 | 2007-11-21 | Academisch Ziekenhuis Leiden | Means and method for inducing exon-skipping |
| AU2008317566B2 (en) * | 2007-10-26 | 2014-05-01 | Academisch Ziekenhuis Leiden | Means and methods for counteracting muscle disorders |
| JP5944311B2 (ja) * | 2009-06-16 | 2016-07-05 | クルナ・インコーポレーテッド | コラーゲン遺伝子に対する天然アンチセンス転写物の抑制によるコラーゲン遺伝子関連疾患の治療 |
| US9340783B2 (en) * | 2011-10-11 | 2016-05-17 | Inserm (Institut National De La Sante Et De La Recherche Medicale | Exon skipping therapy for dystrophic epidermolysis bullosa |
| US9463244B2 (en) | 2013-03-15 | 2016-10-11 | Massachusetts Institute Of Technology | Compositions and methods for nucleic acid delivery |
| JP6871175B2 (ja) | 2015-05-21 | 2021-05-12 | ウィングス セラピューティクス，インコーポレイテッド | ジストロフィー型表皮水疱症を処置するためのアンチセンスオリゴヌクレオチド |
| WO2016196670A1 (en) * | 2015-06-01 | 2016-12-08 | Sarepta Therapeutics, Inc. | Antisense-induced exon exclusion in type vii collagen |
| CA2989371C (en) | 2015-06-15 | 2024-02-06 | Anna-Lena SPETZ HOLMGREN | Single-stranded oligonucleotides for use in the medical treatment of skin disorders |
-
2016
- 2016-05-20 JP JP2017560600A patent/JP6871175B2/ja active Active
- 2016-05-20 MX MX2017014855A patent/MX2017014855A/es unknown
- 2016-05-20 CA CA2986642A patent/CA2986642A1/en active Pending
- 2016-05-20 US US15/575,559 patent/US10370660B2/en active Active
- 2016-05-20 EA EA201792406A patent/EA036393B1/ru unknown
- 2016-05-20 KR KR1020177032446A patent/KR20180012255A/ko active IP Right Grant
- 2016-05-20 IL IL255180A patent/IL255180B2/en unknown
- 2016-05-20 WO PCT/EP2016/061495 patent/WO2016185041A1/en active Application Filing
- 2016-05-20 EP EP16724048.0A patent/EP3298144A1/en active Pending
- 2016-05-20 AU AU2016265457A patent/AU2016265457B2/en active Active
- 2016-05-20 CN CN201680029306.7A patent/CN107667174B/zh active Active
-
2018
- 2018-04-19 HK HK18105119.5A patent/HK1245826A1/zh unknown
-
2019
- 2019-06-17 US US16/442,912 patent/US11104900B2/en active Active
-
2021
- 2021-04-14 JP JP2021068721A patent/JP7188804B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2986642A1 (en) | 2016-11-24 |
| US11104900B2 (en) | 2021-08-31 |
| EA201792406A1 (ru) | 2018-04-30 |
| AU2016265457B2 (en) | 2022-06-09 |
| US20200024601A1 (en) | 2020-01-23 |
| US20180245078A1 (en) | 2018-08-30 |
| IL255180B2 (en) | 2023-11-01 |
| EP3298144A1 (en) | 2018-03-28 |
| CN107667174A (zh) | 2018-02-06 |
| JP2021112197A (ja) | 2021-08-05 |
| IL255180B1 (en) | 2023-07-01 |
| NZ737592A (en) | 2021-08-27 |
| AU2016265457A1 (en) | 2017-12-07 |
| JP2018515122A (ja) | 2018-06-14 |
| CN107667174B (zh) | 2021-10-26 |
| US10370660B2 (en) | 2019-08-06 |
| MX2017014855A (es) | 2018-04-20 |
| KR20180012255A (ko) | 2018-02-05 |
| IL255180A0 (en) | 2017-12-31 |
| JP7188804B2 (ja) | 2022-12-13 |
| JP6871175B2 (ja) | 2021-05-12 |
| EA036393B1 (ru) | 2020-11-05 |
| WO2016185041A1 (en) | 2016-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1258758A1 (zh) | 分支的寡核苷酸 | |
| HRP20190235T1 (hr) | Antisensna nukleinska kiselina | |
| IL256634A (en) | Therapeutic oligonucleotides | |
| IL257091B (en) | Targeted oligonucleotides | |
| GB201711809D0 (en) | Antisense oligonucleotide | |
| GB201503408D0 (en) | Oligonucleotides | |
| IL258065B (en) | Nucleic acids against the coding strand | |
| GB201507926D0 (en) | Improved treatments using oligonucleotides | |
| IL254173A0 (en) | Oligonucleotides corresponding to exon 73 of col7a1 for the treatment of blistering skin | |
| IL251717A0 (en) | Methods and compositions for treating a subject with a smad7 antisense oligonucleotide | |
| IL269151B1 (en) | Antisense oligonucleotides that prevent tgf-r signaling | |
| IL253023A0 (en) | Methods using antisense oligonucleotides for smad7 | |
| SG10201913477UA (en) | G-quadruplex-containing antisense oligonucleotides | |
| SG11201912683QA (en) | Treatment agent for epidermolysis bullosa | |
| HK1245826A1 (zh) | 用於治療營養不良性大疱性表皮鬆解症的反義寡核苷酸 | |
| EP3532617A4 (en) | ANTISENSE OLIGONUCLEOTID | |
| PT3380615T (pt) | Oligonucleótidos antissentido il-34 e métodos de utilização dos mesmos | |
| PL3329004T3 (pl) | Terapeutyczne oligonukleotydy | |
| SG11202012829RA (en) | Acetyl-coa carboxylase2 antisense oligonucleotides | |
| SG10201607303YA (en) | Antisense oligonucleotides to induce exon skipping | |
| HK1223653A1 (zh) | 反義寡核苷酸組合物 | |
| GB201516505D0 (en) | Antisense oligonucleotides | |
| GB201508733D0 (en) | Antisense oligonucleotides | |
| EP3323892A4 (en) | Antisense oligonucleotide inhibition of 2GPI expression | |
| GB201305513D0 (en) | Antisense oligonucleotides or oligonucleotide analogues |